{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:16:48Z","timestamp":1793945808705,"version":"4.8.0"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T00:00:00Z","timestamp":1670371200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011842","name":"Opetushallitus","doi-asserted-by":"publisher","award":["KM-18-10822"],"award-info":[{"award-number":["KM-18-10822"]}],"id":[{"id":"10.13039\/501100011842","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.jgar.2022.11.016","type":"journal-article","created":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T02:48:47Z","timestamp":1670986127000},"page":"35-43","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["Antimicrobial resistance prevalence of Escherichia coli and Staphylococcus aureus amongst bacteremic patients in Africa: a systematic review"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7094-6569","authenticated-orcid":false,"given":"Erastus Hanganeni","family":"Haindongo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Ndakolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marius","family":"Hedimbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olli","family":"Vainio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4180-0306","authenticated-orcid":false,"given":"Antti","family":"Hakanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaana","family":"Vuopio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2022.11.016_bib0001","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1179\/2047773215Y.0000000030","article-title":"Antimicrobial resistance: a global multifaceted phenomenon","volume":"109","author":"Prestinaci","year":"2015","journal-title":"Pathog Glob Health"},{"key":"10.1016\/j.jgar.2022.11.016_bib0002","unstructured":"World Health Organization. Antimicrobial resistance 2021. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/antimicrobial-resistance [accessed 13.06.2022]."},{"key":"10.1016\/j.jgar.2022.11.016_bib0003","series-title":"Review on antimicrobial resistance. antimicrobial resistance: tackling a crisis for the health and wealth of nations","author":"O'Neill","year":"2014"},{"key":"10.1016\/j.jgar.2022.11.016_bib0004","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","author":"Murray","year":"2022","journal-title":"The Lancet"},{"key":"10.1016\/j.jgar.2022.11.016_bib0005","unstructured":"World Health Organization. Global antimicrobial resistance and use surveillance system (GLASS) report: 2021 2021."},{"key":"10.1016\/j.jgar.2022.11.016_bib0006","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/d41586-017-08323-0","article-title":"Deploy vaccines to fight superbugs","volume":"552","author":"Rappuoli","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jgar.2022.11.016_bib0007","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/s10393-019-01415-5","article-title":"Critical importance of a One Health approach to antimicrobial resistance","volume":"16","author":"White","year":"2019","journal-title":"Ecohealth"},{"key":"10.1016\/j.jgar.2022.11.016_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.onehlt.2021.100220","article-title":"One Health drivers of antibacterial resistance: quantifying the relative impacts of human, animal and environmental use and transmission","volume":"12","author":"Booton","year":"2021","journal-title":"One Health"},{"key":"10.1016\/j.jgar.2022.11.016_bib0009","first-page":"33703","article-title":"One Health training and research activities in Western Europe","volume":"6","author":"Sikkema","year":"2016","journal-title":"Infect Ecol Epidemiol"},{"key":"10.1016\/j.jgar.2022.11.016_bib0010","series-title":"Global Burden of Disease Study 2019","year":"2022"},{"key":"10.1016\/j.jgar.2022.11.016_bib0011","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.DMIH2-0031-2016","article-title":"Bloodstream infections","volume":"4","author":"Martinez","year":"2016","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.jgar.2022.11.016_bib0012","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jgar.2021.09.018","article-title":"Trends in antimicrobial resistance in bloodstream infections at a large tertiary-care hospital in China: a 10-year retrospective study (2010\u20132019)","volume":"29","author":"Liu","year":"2021","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.jgar.2022.11.016_bib0013","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.jgar.2021.10.022","article-title":"Global prevalence and molecular epidemiology of mcr-mediated colistin resistance in Escherichia coli clinical isolates: a systematic review","volume":"29","author":"Dadashi","year":"2021","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.jgar.2022.11.016_bib0014","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/1469-0691.12144","article-title":"Incidence of bloodstream infection: a review of population-based studies","volume":"19","author":"Laupland","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jgar.2022.11.016_bib0015","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S1473-3099(17)30491-7","article-title":"Patterns of bacteraemia aetiology","volume":"17","author":"Cross","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jgar.2022.11.016_bib0016","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1097\/INF.0b013e3181958769","article-title":"Pathogens associated with sepsis in newborns and young infants in developing countries","volume":"28","author":"Zaidi","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jgar.2022.11.016_bib0017","first-page":"23198116","article-title":"Aetiology of community-acquired neonatal sepsis in low and middle income countries","volume":"1","author":"Waters","year":"2011","journal-title":"J Glob Health"},{"key":"10.1016\/j.jgar.2022.11.016_bib0018","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s13756-019-0673-5","article-title":"Bacterial pathogens and resistance causing community acquired paediatric bloodstream infections in low- and middle-income countries: a systematic review and meta-analysis","volume":"8","author":"Droz","year":"2019","journal-title":"Antimicrob Resist Infect Control"},{"key":"10.1016\/j.jgar.2022.11.016_bib0019","doi-asserted-by":"crossref","first-page":"191","DOI":"10.7705\/biomedica.v34i0.2210","article-title":"Resistencia a antibi\u00f3ticos de \u00faltima l\u00ednea en cocos Gram positivos: la era posterior a la vancomicina","volume":"34","author":"Rinc\u00f3n","year":"2014","journal-title":"Biom\u00e9dica"},{"key":"10.1016\/j.jgar.2022.11.016_bib0020","doi-asserted-by":"crossref","unstructured":"McKenna M. The last resort: health officials are watching in horror as bacteria become resistant to powerful carbapenem antibiotics\u2013one of the last drugs on the shelf. Nature 2013;499:394. doi:10.1038\/499394a.","DOI":"10.1038\/499394a"},{"key":"10.1016\/j.jgar.2022.11.016_bib0021","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3389\/fpubh.2016.00209","article-title":"Current state of resistance to antibiotics of last-resort in South Africa: a review from a public health perspective","volume":"4","author":"Osei Sekyere","year":"2016","journal-title":"Front Public Health"},{"key":"10.1016\/j.jgar.2022.11.016_bib0022","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1080\/14787210.2016.1216314","article-title":"On the path to untreatable infections: colistin use in agriculture and the end of \u2018last resort\u2019 antibiotics","volume":"14","author":"Watkins","year":"2016","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.jgar.2022.11.016_bib0023","doi-asserted-by":"crossref","unstructured":"Juh\u00e1s M, Bacht\u00edkov\u00e1 A, Nawrot DE, Hatokov\u00e1 P, Pallabothula VSK, Diepoltov\u00e1 A, et\u00a0al. Improving antimicrobial activity and physico-chemical properties by isosteric replacement of 2-aminothiazole with 2-aminooxazole. Pharmaceuticals 2022;15:580. doi:10.3390\/ph15050580.","DOI":"10.3390\/ph15050580"},{"key":"10.1016\/j.jgar.2022.11.016_bib0024","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1007\/s10096-005-0055-1","article-title":"Antimicrobial agents for treatment of serious infections caused by resistant Staphylococcus aureus and enterococci","volume":"24","author":"Eliopoulos","year":"2005","journal-title":"Euro J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jgar.2022.11.016_bib0025","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1093\/cid\/cit614","article-title":"Methicillin-resistant Staphylococcus aureus therapy: past, present, and future","volume":"58","author":"Rodvold","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2022.11.016_bib0026","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.2147\/IDR.S358788","article-title":"Antimicrobial susceptibility trends among Gram-negative bacilli causing bloodstream infections: results from the China Antimicrobial Resistance Surveillance Trial (CARST) program, 2011\u20132020","volume":"15","author":"Yan","year":"2022","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.jgar.2022.11.016_bib0027","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jmii.2010.06.001","article-title":"Risk factors and outcomes of carbapenem-nonsusceptible Escherichia coli bacteremia: a matched case\u2013control study","volume":"44","author":"Chang","year":"2011","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jgar.2022.11.016_bib0028","doi-asserted-by":"crossref","unstructured":"Myat TO, Hannaway RF, Zin KN, Htike WW, Win KK, Crump JA, et\u00a0al. ESBL- and carbapenemase-producing Enterobacteriaceae in patients with bacteremia, Yangon, Myanmar, 2014. Emerg Infect Dis 2017;23:857\u2013859. doi:10.3201\/eid2305.161100.","DOI":"10.3201\/eid2305.161100"},{"key":"10.1016\/j.jgar.2022.11.016_bib0029","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.3390\/ijerph17041395","article-title":"Outcome impacts due to pathogen-specific antimicrobial resistance: a narrative review of published literature","volume":"17","author":"Jiang","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.jgar.2022.11.016_bib0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0125155","article-title":"Trumble Waddell J An assessment of antimicrobial resistant disease threats in Canada","volume":"10","author":"Garner","year":"2015","journal-title":"PLOS One"},{"key":"10.1016\/j.jgar.2022.11.016_bib0031","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2017-000518","article-title":"Antimicrobial resistance and universal health coverage","volume":"2","author":"Bloom","year":"2017","journal-title":"BMJ Global Health"},{"key":"10.1016\/j.jgar.2022.11.016_bib0032","doi-asserted-by":"crossref","first-page":"100171","DOI":"10.1016\/j.onehlt.2020.100171","article-title":"Opportunities and challenges in antimicrobial resistance behavior change communication","volume":"11","author":"Othieno","year":"2020","journal-title":"One Health"},{"key":"10.1016\/j.jgar.2022.11.016_bib0033","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.jiph.2018.05.007","article-title":"Antimicrobial resistance: a round table discussion on the \u2018One Health\u2019 concept from the Gulf Cooperation Council Countries. Part one: a focus on leadership","volume":"11","author":"Balkhy","year":"2018","journal-title":"J Infect Public Health"},{"key":"10.1016\/j.jgar.2022.11.016_bib0034","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003873","article-title":"Political rationale, aims, and outcomes of health-related high-level meetings and special sessions at the UN General Assembly: a policy research observational study","volume":"19","author":"Rodi","year":"2022","journal-title":"PLOS Medicine"},{"key":"10.1016\/j.jgar.2022.11.016_bib0035","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jgar.2018.08.014","article-title":"Determinants of methicillin-resistant Staphylococcus aureus (MRSA) prevalence in the Asia-Pacific region: a systematic review and meta-analysis","volume":"16","author":"Lim","year":"2019","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.jgar.2022.11.016_bib0036","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0068024","article-title":"MRSA in Africa: filling the global map of antimicrobial resistance","volume":"8","author":"Falagas","year":"2013","journal-title":"PLOS One"},{"key":"10.1016\/j.jgar.2022.11.016_bib0037","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/1471-2334-11-138","article-title":"MRSA prevalence in European healthcare settings: a review","volume":"11","author":"Dulon","year":"2011","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jgar.2022.11.016_bib0038","unstructured":"European Centre for Disease Prevention and Control. Surveillance atlas of infectious diseases 2019. http:\/\/atlas.ecdc.europa.eu\/public\/index.aspx [accessed: 4.10.2022]."},{"key":"10.1016\/j.jgar.2022.11.016_bib0039","doi-asserted-by":"crossref","first-page":"10306","DOI":"10.7189\/jogh.06.010306","article-title":"Global disease burden due to antibiotic resistance - state of the evidence","volume":"6","author":"Woolhouse","year":"2016","journal-title":"J Glob Health"},{"key":"10.1016\/j.jgar.2022.11.016_bib0040","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1093\/jac\/dkt500","article-title":"Proportion of extended-spectrum \u03b2-lactamase (ESBL)-producing isolates among Enterobacteriaceae in Africa: evaluation of the evidence-systematic review","volume":"69","author":"Tansarli","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2022.11.016_bib0041","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1016\/j.ajic.2011.04.009","article-title":"Antimicrobial resistance in pathogens causing nosocomial bloodstream infections in university hospitals in Egypt","volume":"39","author":"Saied","year":"2011","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.jgar.2022.11.016_bib0042","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/jac\/dkl037","article-title":"Identification and characterization of ceftriaxone resistance and extended-spectrum \u03b2-lactamases in Malawian bacteraemic Enterobacteriaceae","volume":"57","author":"Gray","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2022.11.016_bib0043","unstructured":"European Centre for Disease Prevention and Control. Antimicrobial resistance in the EU\/EEA (EARS-Net) - Annual Epidemiological Report 2019. Stockholm: 2020."},{"key":"10.1016\/j.jgar.2022.11.016_bib0044","doi-asserted-by":"crossref","first-page":"106535","DOI":"10.1016\/j.ijantimicag.2022.106535","article-title":"Prevalence of ESBL non-CRE Escherichia coli and Klebsiella pneumoniae among clinical isolates collected by the SMART global surveillance programme from 2015 to 2019","volume":"59","author":"Karlowsky","year":"2022","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jgar.2022.11.016_bib0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0202276","article-title":"Molecular epidemiology and clinical features of extended-spectrum beta-lactamase- or carbapenemase-producing Escherichia coli bacteremia in Japan","volume":"13","author":"Komatsu","year":"2018","journal-title":"PLOS One"},{"key":"10.1016\/j.jgar.2022.11.016_bib0046","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01896-13","article-title":"Contemporary diversity of \u03b2-lactamases among Enterobacteriaceae in the nine U.S. census regions and ceftazidime-avibactam activity tested against isolates producing the most prevalent \u03b2-lactamase groups","volume":"58","author":"Castanheira","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2022.11.016_bib0047","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0220265","article-title":"The burden of antimicrobial resistance among urinary tract isolates of Escherichia coli in the United States in 2017","volume":"14","author":"Critchley","year":"2019","journal-title":"PLOS One"},{"key":"10.1016\/j.jgar.2022.11.016_bib0048","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jgar.2017.07.018","article-title":"Current epidemiology of resistance among Gram-negative bacilli in paediatric patients in Turkey","volume":"11","author":"Aykac","year":"2017","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.jgar.2022.11.016_bib0049","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.3390\/ph6111335","article-title":"A review of ten years of the Study for Monitoring Antimicrobial Resistance Trends (SMART) from 2002 to 2011","volume":"6","author":"Morrissey","year":"2013","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.jgar.2022.11.016_bib0050","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s13756-021-00997-6","article-title":"The epidemiology of bloodstream infections and antimicrobial susceptibility patterns in Thuringia, Germany: a five-year prospective, state-wide surveillance study (AlertsNet)","volume":"10","author":"Sch\u00f6neweck","year":"2021","journal-title":"Antimicrob Resist Infect Control"},{"key":"10.1016\/j.jgar.2022.11.016_bib0051","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1017\/ice.2015.239","article-title":"Increasing incidence of extended-spectrum \u03b2-lactamase\u2013producing Escherichia coli in community hospitals throughout the southeastern United States","volume":"37","author":"Thaden","year":"2016","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jgar.2022.11.016_bib0052","first-page":"70","article-title":"Trend in antibiotic resistance of extended-spectrum beta-lactamase\u2013producing Escherichia coli and Klebsiella pneumoniae bloodstream infections. Sisli Etfal Hastanesi Tip","volume":"53","author":"Bayraktar","year":"2019","journal-title":"Bulteni"},{"key":"10.1016\/j.jgar.2022.11.016_bib0053","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12941-017-0236-7","article-title":"Extended spectrum beta-lactamase and metallo beta-lactamase production among Escherichia coli and Klebsiella pneumoniae isolated from different clinical samples in a tertiary care hospital in Kathmandu, Nepal","volume":"16","author":"Nepal","year":"2017","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"10.1016\/j.jgar.2022.11.016_bib0054","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13099-021-00441-5","article-title":"Antibiotic resistance and detection of plasmid mediated colistin resistance mcr-1 gene among Escherichia coli and Klebsiella pneumoniae isolated from clinical samples","volume":"13","author":"Karki","year":"2021","journal-title":"Gut Pathog"},{"key":"10.1016\/j.jgar.2022.11.016_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijid.2015.07.010","article-title":"Prevalence, risk factors, and impact on clinical outcome of extended-spectrum beta-lactamase\u2013producing Escherichia coli bacteraemia: a five-year study","volume":"39","author":"Denis","year":"2015","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jgar.2022.11.016_bib0056","doi-asserted-by":"crossref","first-page":"5873","DOI":"10.1128\/AAC.01019-15","article-title":"Carbapenemase-producing Klebsiella pneumoniae, a key pathogen set for global nosocomial dominance","volume":"59","author":"Pitout","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2022.11.016_bib0057","doi-asserted-by":"crossref","unstructured":"Haindongo EH, Funtua B, Singu B, Hedimbi M, Kalemeera F, Hamman J, et\u00a0al. Antimicrobial resistance among bacteria isolated from urinary tract infections in females in Namibia, 2016\u20132017. Antimicrob Resist Infect Control 2022;11:33. doi:10.1186\/s13756-022-01066-2","DOI":"10.1186\/s13756-022-01066-2"},{"key":"10.1016\/j.jgar.2022.11.016_bib0058","article-title":"Antimicrobial resistance patterns, clinical features, and risk factors for septic shock and death of nosocomial E. coli bacteremia in adult patients with hematological disease","volume":"96","author":"Ma","year":"2017","journal-title":"Medicine"},{"key":"10.1016\/j.jgar.2022.11.016_bib0059","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3201\/eid2401.171112","article-title":"Antimicrobial drug resistance in blood culture isolates at a tertiary hospital","volume":"24","author":"Kajumbula","year":"2018","journal-title":"Uganda. Emerg Infect Dis"},{"key":"10.1016\/j.jgar.2022.11.016_bib0060","doi-asserted-by":"crossref","first-page":"403","DOI":"10.33073\/pjm-2019-048","article-title":"Antibiotic resistance among uropathogenic Escherichia coli","volume":"68","author":"Kot","year":"2019","journal-title":"Pol J Microbiol"},{"key":"10.1016\/j.jgar.2022.11.016_bib0061","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1080\/00325481.2019.1680052","article-title":"Treatment of urinary tract infections in the era of antimicrobial resistance and new antimicrobial agents","volume":"132","author":"Bader","year":"2020","journal-title":"Postgrad Med"},{"key":"10.1016\/j.jgar.2022.11.016_bib0062","first-page":"1","article-title":"The antibiotic resistance profiles of bacterial strains isolated from patients with hospital-acquired bloodstream and urinary tract infections","volume":"2012","author":"Ghadiri","year":"2012","journal-title":"Crit Care Res Pract"},{"key":"10.1016\/j.jgar.2022.11.016_bib0063","unstructured":"Jadoon RJ, Jalal-ud-Din M, Khan SA. E. coli resistance to ciprofloxacin and common associated factors. J Coll Physicians Surg Pak 2015;25:824\u2013827. PMID: 26577970."},{"key":"10.1016\/j.jgar.2022.11.016_bib0064","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.3201\/eid1910.130309","article-title":"Multidrug-resistant Escherichia coli bacteremia","volume":"19","author":"Alhashash","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jgar.2022.11.016_bib0065","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1097\/INF.0000000000000652","article-title":"Antibiotic resistance prevalence in routine bloodstream isolates from children\u2019s hospitals varies substantially from adult surveillance data in Europe","volume":"34","author":"Bielicki","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jgar.2022.11.016_bib0066","article-title":"Five-year antimicrobial resistance patterns of urinary Escherichia coli at an Australian tertiary hospital: time series analyses of prevalence data","volume":"1","author":"Fasugba","year":"2016","journal-title":"PLOS One"},{"key":"10.1016\/j.jgar.2022.11.016_bib0067","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1473-3099(14)71011-4","article-title":"The expanding role of co-trimoxazole in developing countries","volume":"15","author":"Church","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jgar.2022.11.016_bib0068","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/jac\/dkp162","article-title":"Antimicrobial resistance trends of Escherichia coli bloodstream isolates: a population-based study, 1998\u20132007","volume":"64","author":"Al-Hasan","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2022.11.016_bib0069","article-title":"High resistance prevalence towards ampicillin, co-trimoxazole and ciprofloxacin, among uropathogenic Escherichia coli isolates in Mexico City","volume":"2","author":"Arredondo-Garc\u00eda","year":"2008","journal-title":"J Infect Dev Ctries"},{"key":"10.1016\/j.jgar.2022.11.016_bib0070","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1111\/j.1365-3156.2011.02822.x","article-title":"Antimicrobial susceptibility of bacterial isolates from community acquired infections in sub-Saharan Africa and Asian low and middle income countries","volume":"16","author":"Ashley","year":"2011","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.jgar.2022.11.016_bib0071","first-page":"9","article-title":"Assessment of bacterial profile and antimicrobial susceptibility pattern of blood culture isolates","volume":"17","author":"Cheema","year":"2022","journal-title":"J Islam Int Med Coll"},{"key":"10.1016\/j.jgar.2022.11.016_bib0072","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2147\/IDR.S344875","article-title":"Antimicrobial resistance among pathogens causing bloodstream infections: a multicenter surveillance report over 20 years (1998\u20132017)","volume":"15","author":"Zhang","year":"2022","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.jgar.2022.11.016_bib0073","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1159\/000224657","article-title":"Prevalence and antimicrobial resistance patterns of extended-spectrum \u03b2-lactamase\u2013producing Escherichia coli and Klebsiella pneumoniae isolated from blood cultures in an Istanbul university hospital","volume":"55","author":"Koksal","year":"2009","journal-title":"Chemother"},{"key":"10.1016\/j.jgar.2022.11.016_bib0074","unstructured":"Datta S, Wattal C, Goel N, Oberoi JK, Raveendran R, Prasad KJ. A ten year analysis of multi-drug resistant blood stream infections caused by Escherichia coli and Klebsiella pneumoniae in a tertiary care hospital. Indian J Med Res 2012;135:907\u2013912. PMCID: PMC3410219."},{"key":"10.1016\/j.jgar.2022.11.016_bib0075","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/j.1469-0691.2004.00919.x","article-title":"Evaluation of a cefoxitin disk diffusion test for the routine detection of methicillin-resistant Staphylococcus aureus","volume":"10","author":"Boutiba-Ben Boubaker","year":"2004","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jgar.2022.11.016_bib0076","article-title":"Comparison of polymerase chain reaction and conventional methods in detecting methicillin-resistant Staphylococcus aureus","volume":"2","author":"Adaleti","year":"2008","journal-title":"J Infect Dev Ctries"},{"key":"10.1016\/j.jgar.2022.11.016_bib0077","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s10096-011-1207-0","article-title":"Evaluation of discrepancies between oxacillin and cefoxitin disk susceptibility for detecting methicillin-resistant Staphylococcus aureus","volume":"30","author":"Hung","year":"2011","journal-title":"Euro J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jgar.2022.11.016_bib0078","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1089\/mdr.2020.0361","article-title":"Comparison of phenotypic MRSA detection methods with PCR for mecA gene in the background of emergence of oxacillin-susceptible MRSA","volume":"27","author":"Nair","year":"2021","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.jgar.2022.11.016_bib0079","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1128\/JCM.01109-09","article-title":"BD Phoenix and Vitek 2 Detection of mecA-mediated resistance in Staphylococcus aureus with cefoxitin","volume":"47","author":"Junkins","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jgar.2022.11.016_bib0080","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1099\/jmm.0.032219-0","article-title":"Evaluation of various methods for the detection of meticillin-resistant Staphylococcus aureus strains and susceptibility patterns","volume":"60","author":"Datta","year":"2011","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.jgar.2022.11.016_bib0081","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1128\/am.24.2.240-247.1972","article-title":"Reliability of the Kirby-Bauer disc diffusion method for detecting methicillin-resistant strains of Staphylococcus aureus","volume":"24","author":"Drew","year":"1972","journal-title":"App Microbiol"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221371652200265X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221371652200265X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T09:59:16Z","timestamp":1761991156000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221371652200265X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":81,"alternative-id":["S221371652200265X"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2022.11.016","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antimicrobial resistance prevalence of Escherichia coli and Staphylococcus aureus amongst bacteremic patients in Africa: a systematic review","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2022.11.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy.","name":"copyright","label":"Copyright"}]}}